Company / Working Capital per Share
Oric Pharmaceuticals, Inc. Working Capital per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$3.05
FY2025
5-year range
$3.05 / $5.94
FY2021-FY2025
Trend
-10.3%
vs FY2024
Sector context
#142 of 210
Health Care
What the data says
At $3.05, Oric Pharmaceuticals, Inc.'s working capital per share ranks #142 of 210 in the Health Care sector. Working Capital per Share has declined for 6 consecutive years, from $44.57 in FY2019 to $3.05 in FY2025.
Based on SEC 10-K filings.
3.05 in FY2025 with a 5-year CAGR of -25.3%.
Declined from $3.73 to $3.05 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -14.7%
- 5-Year CAGR
- -25.3%
- 10-Year CAGR
- -
Sector benchmark
#142 of 210 in Health CareTop 68% of 210This company $3.05 Sector average $146.86
▼
-97.9% below sector average
Key checks
Key Insights
- Oric Pharmaceuticals, Inc.'s working capital per share has declined for 6 consecutive years.
- In FY2025, working capital per share decreased 10.3% year-over-year.
- Ranks #142 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score 5.96 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.05 | -10.3% |
| FY2024 | $3.40 | -8.8% |
| FY2023 | $3.73 | -24.1% |
| FY2022 | $4.92 | -17.2% |
| FY2021 | $5.94 | -54.7% |
| FY2020 | $13.11 | -70.6% |
| FY2019 | $44.57 | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026